Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 364 participants.
Also called NCT02494284
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 364 participants
- Sponsor
- Registry
-
NCT02494284
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Terminated
Technical summary
Registry record NCT02494284. Randomized; no masking; primary purpose treatment. Start 2015-12-22 (actual); primary completion 2017-02-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
- Acronym
- STAMP-DES
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Aspirin plus clopidogrel
- Lead sponsor
- CHEOL WHAN LEE, M.D., Ph.D
- Collaborator
- CardioVascular Research Foundation, Korea
- Collaborator
- Medtronic
- Collaborator
- Chong Kun Dang Pharmaceutical Corp.
Record details
- Record id
cardio:ct-nct02494284- Content hash
9a6eab178b502791673351db9ae3c8a7c9558c7531686a8adcfedc341dabeefe